[go: up one dir, main page]

BRPI0519157A2 - composiÇço, e, uso da mesma - Google Patents

composiÇço, e, uso da mesma

Info

Publication number
BRPI0519157A2
BRPI0519157A2 BRPI0519157-2A BRPI0519157A BRPI0519157A2 BR PI0519157 A2 BRPI0519157 A2 BR PI0519157A2 BR PI0519157 A BRPI0519157 A BR PI0519157A BR PI0519157 A2 BRPI0519157 A2 BR PI0519157A2
Authority
BR
Brazil
Prior art keywords
composition
solvent
chloroamphenicol
fluorinated
polymers
Prior art date
Application number
BRPI0519157-2A
Other languages
English (en)
Inventor
Carole Barbot
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI0519157A2 publication Critical patent/BRPI0519157A2/pt
Publication of BRPI0519157B1 publication Critical patent/BRPI0519157B1/pt
Publication of BRPI0519157B8 publication Critical patent/BRPI0519157B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIÇçO, E, USO DA MESMA. Composição veterinária injetável, que compreende um derivado de cloroanfenicol ou tiamfenicol fluorado e um sistema de solvente, que compreende um éter de 1 ,2-etanodiol, ou polimeros e um solvente pirrolidona.
BRPI0519157A 2004-12-21 2005-12-20 composição, e, uso da mesma BRPI0519157B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63815404P 2004-12-21 2004-12-21
EP04106809 2004-12-21
PCT/EP2005/056950 WO2006067138A2 (en) 2004-12-21 2005-12-20 Injectable veterinary composition

Publications (3)

Publication Number Publication Date
BRPI0519157A2 true BRPI0519157A2 (pt) 2008-12-30
BRPI0519157B1 BRPI0519157B1 (pt) 2020-05-19
BRPI0519157B8 BRPI0519157B8 (pt) 2020-06-02

Family

ID=36498916

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519157A BRPI0519157B8 (pt) 2004-12-21 2005-12-20 composição, e, uso da mesma

Country Status (17)

Country Link
US (1) US8680154B2 (pt)
EP (1) EP1830885B1 (pt)
JP (1) JP5017122B2 (pt)
AR (1) AR052827A1 (pt)
AT (1) ATE411046T1 (pt)
AU (1) AU2005318187B2 (pt)
BR (1) BRPI0519157B8 (pt)
CA (1) CA2591307C (pt)
DE (1) DE602005010479D1 (pt)
DK (1) DK1830885T3 (pt)
ES (1) ES2315942T3 (pt)
MX (1) MX2007007528A (pt)
NO (1) NO338532B1 (pt)
PL (1) PL1830885T3 (pt)
PT (1) PT1830885E (pt)
SI (1) SI1830885T1 (pt)
WO (1) WO2006067138A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044437A1 (es) * 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
EP2102154A1 (en) * 2006-12-13 2009-09-23 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
FR2925335B1 (fr) * 2007-12-21 2010-03-19 Ceva Sante Animale Compositions orales liquides de florfenicol diluables dans l'eau de boisson
KR20110038723A (ko) * 2008-07-30 2011-04-14 인터벳 인터내셔널 비.브이. 플로르페니콜에 대한 중간체로서 유용한 옥사졸린-보호된 아미노디올 화합물의 제조 방법
BRPI1002021A2 (pt) 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN102973498A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种氟苯尼考注射液及其制备方法
UA119324C2 (uk) 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
CN108969486A (zh) * 2018-06-05 2018-12-11 王琴 一种氟苯尼考可溶性粉及其制备方法
CN108653213A (zh) * 2018-06-05 2018-10-16 王琴 一种氟苯尼考粉及其制备方法
CN108743541A (zh) * 2018-06-24 2018-11-06 王琴 水溶性兽药制剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52533A (en) 1977-07-15 1980-01-31 Abic Ltd Injectable chloramphenicol composition
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
ES8104203A1 (es) * 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
IT1173213B (it) * 1984-02-03 1987-06-18 Zambon Spa Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
US5332835A (en) * 1984-02-03 1994-07-26 Zambon S.P.A. Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process
US4582918A (en) * 1984-09-19 1986-04-15 Schering Corporation Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4973750A (en) * 1984-09-19 1990-11-27 Schering Corporation Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
IT1197481B (it) * 1986-09-15 1988-11-30 Zambon Spa Preparazione farmaceutica per uso veterinario
US4876352A (en) * 1988-09-14 1989-10-24 Schering Corporation Pressurized fluorination of hydroxy alkyl groups
US5227494A (en) * 1988-09-14 1993-07-13 Schering Corporation Process for preparing oxazoline compounds
US5082863A (en) 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
DE69105752T2 (de) * 1990-10-25 1995-05-11 Schering Corp., Kenilworth, N.J. Verfahren zur herstellung von florfenicol, seine analoga und oxazolinzwischenprodukte.
US5352832A (en) * 1992-12-18 1994-10-04 Schering Corporation Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
EP0621033A1 (en) 1993-04-20 1994-10-26 Nostras S.A. Antibiotic composition containing oxytetracycline and glycofurol
US5663361A (en) * 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
KR20040015623A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 플로르페니콜을 활성성분으로 함유하는 주사액 조성물
KR20040015624A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물
AR044437A1 (es) * 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino

Also Published As

Publication number Publication date
ES2315942T3 (es) 2009-04-01
JP2008524311A (ja) 2008-07-10
WO2006067138A2 (en) 2006-06-29
DE602005010479D1 (de) 2008-11-27
NO20072880L (no) 2007-07-19
WO2006067138A3 (en) 2006-09-21
MX2007007528A (es) 2007-10-08
CA2591307C (en) 2012-12-04
US20090275662A1 (en) 2009-11-05
NO338532B1 (no) 2016-08-29
BRPI0519157B1 (pt) 2020-05-19
AU2005318187B2 (en) 2010-12-16
DK1830885T3 (da) 2009-01-05
AU2005318187A1 (en) 2006-06-29
SI1830885T1 (sl) 2009-02-28
US8680154B2 (en) 2014-03-25
EP1830885B1 (en) 2008-10-15
PL1830885T3 (pl) 2009-04-30
JP5017122B2 (ja) 2012-09-05
PT1830885E (pt) 2008-12-22
CA2591307A1 (en) 2006-06-29
EP1830885A2 (en) 2007-09-12
ATE411046T1 (de) 2008-10-15
AR052827A1 (es) 2007-04-04
BRPI0519157B8 (pt) 2020-06-02

Similar Documents

Publication Publication Date Title
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
BRPI0410555A (pt) preparação sólida
UY28348A1 (es) Compuestos novedosos
HN2006019066A (es) "(s)-n-metilnaltrexona"
CR9786A (es) Compuestos de bencimidazol-tiofeno
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
BR0005011B1 (pt) mecanismo de soltura rápida para uso com respirador, testeira para uso com um respirador e respirador.
UY27346A1 (es) Composiciones farmaccuticas que contienen conjuntos de polemero y frrmaco.
BRPI0519157A2 (pt) composiÇço, e, uso da mesma
BRPI0614087B8 (pt) seringa de uso único com sistema de redução de impulso
CL2008001749A1 (es) Formulacion acuosa para el tratamiento de materiales no vivientes que comprende un plaguicida, un aglutinante polimerico y agua o mezcla acuosa de disolventes; su procedimiento de preparacion; procedimiento para preparar materiales no vivientes con plaguicida; material no viviente impregnado; y uso de dicho material.
CL2003002731A1 (es) Compuesto derivado de quinazolina de formula definida, que actua como inhibidor de la kinasa aurora; procedimiento de preparacion del compuesto; composicion farmaceutica que comprende al compuesto y uso del compuesto; util para el tratamiento de enfe
CL2007002971A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
BRPI0601896A (pt) composições que contêm microgéis e agentes espessantes
HN2004000109A (es) Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso
CL2007002970A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CR9364A (es) Agentes endoparasiticidas
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
BR0314241B1 (pt) composto, processos para a preparaÇço do mesmo e para a carbonilaÇço de um composto etilenicamente insaturado, composiÇço, e, uso de um composto ou de uma composiÇço.
BR0116152B1 (pt) aditivo adequado para uso como emulsificador e solubilizador, uso de um aditivo, e, composição.
UY29889A1 (es) Agentes fitosanitarios sólidos con contenido de polialcoxilato, procedimiento para su preparación y su uso
BRPI0409330A (pt) eliminador de oxigênio ativo derivado de substáncia natural e seu uso
ATE409040T1 (de) Kombination enthaltend substanzen mit npy- rezeptor affinität und substanzen mit 5-ht6- rezeptor affinität
ES2174297T3 (es) Nuevos derivados de piranosidos.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2576 DE 19/05/2020 QUANTO AO ENDERECO.